Piper Sandler began coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued on Friday, MarketBeat reports. The firm set an “overweight” rating and a $48.00 ...

President Trump’s first-month policy blitz is putting that resilience to the test. It’s far too early to say if cracks are ...

Best Stocks To Invest In. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) ...